Pfizer Invests $500 Million To Advance State-Of-The-Art Gene Therapy Facility In Sanford, North Caro

Specifications:

Name:

Pfizer Invests $500 Million To Advance State-Of-The-Art Gene Therapy Facility In Sanford, North Caro

Location:

North Carolina

Company:

Pfizer

Estimated Cost:

$500 Million

Source:

www.pfizer.com

Introduction:

Pfizer invests $500 Million for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.

Features:

By expanding its manufacturing footprint in Sanford, Pfizer expects to strengthen its ability to produce and supply both clinical- and commercial-scale quantities of critical, potentially life-changing gene therapy medicines to patients living with rare diseases around the world. Specifically, the new facility would help advance Pfizer’s work in manufacturing highly specialized, potentially one-time gene therapies that use custom-made recombinant adeno-associated virus (rAAV) vectors.

This facility would expand the company’s presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford. The expanded facility is projected to add approximately 300 new jobs.

In addition to its gene therapy operations, colleagues at Pfizer’s Sanford facility also manufacture components for the company’s vaccine portfolio, including Prevnar 13 and several vaccines currently in Pfizer’s research pipeline.